Skyscape Web Viewer : EBMG: Pulmonary Diseases : Main Index

View All
Antimicrobial prophylaxis
Antimicrobial resistance
Change
Chapping
Charcot arthropathy
Charcot joint
Charcot-Marie-Tooth
Charcot-Marie-Tooth Disease Ascorbic Acid for the Treatment of Charcot-Marie-Tooth Disease Cochrane review Evidence summary Female Interventions for Increasing Ankle Range of Motion in Patients with Neuromuscular Disease Neurology Polyneuropathies - Related Resources Rehabilitation for Foot Drop in Neuromuscular Disease Systematic review
Charcot-Marie-Tooth Disease
Charcot-Marie-Tooth Disease
Charnley prosthesis Femoral Fractures - Related Resources Osteoarthritis - Related Resources Outcomes and Cost-Effectiveness of Primary Total Hip Replacement with Different Prostheses
Chauffeur's fracture
CHC Combination Contraceptives: Effects on Weight Hormonal Contraception in Overweight or Obese Women Ischaemic Stroke and Myocardial Infarction Risk with Combined Oral Contraceptives Risk of Myocardial Infarction in Users of Third Generation Oral Contraceptives
Antimicrobial therapy
Antimicrobial therapy
Antimicrobial therapy
Antimicrobial treatment
Antimonials
Antimony
Antimotility agents Adsorbents for Chronic Diarrhoea in People with HIV/AIDS HIV Infection - Related Resources
Antimuscarins
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal Aromatase Inhibitors Vs. Tamoxifen in Postmenopausal Women with Early Breast Cancer Chemotherapy Alone Versus Endocrine Therapy Alone for Metastatic Breast Cancer Combined Chemo-Endocrine Adjuvant Therapy for Patients with Operable Breast Cancer Fulvestrant for Hormone-Sensitive Metastatic Breast Cancer Hormonal Therapy in Advanced or Recurrent Endometrial Cancer Progestogens and other Hormone Therapies in Women with Breast Cancer and Bone Metastasis Surgery or Tamoxifen for Primary Breast Cancer in Elderly Women Tamoxifen for Premenopausal Early Breast Cancer Tamoxifen in Chemoprevention of Breast Cancer Taxane Containing Regimens for Metastatic Breast Cancer
Antineoplastic Agents, Phytogenic
CHD events Aspirin for the Primary Prevention of Cardiovascular Events Estrogen Plus Progestin for Primary Prevention in Healthy Postmenopausal Women Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women Fibrates for Primary Prevention of Cardiovascular Disease Hormone Replacement Therapy and the Risk of Stroke Long Term Hormone Therapy for Perimenopausal and Postmenopausal Women for Chronic Conditions Omega-3 Fatty Acids for Prevention of Cardiovascular Disease Plasma Homocysteine Level as a Risk Factor for Major Coronary Events Reduced Saturated Fat for Preventing Cardiovascular Disease
CHD
Checklists Differential Diagnosis of Mole and Melanoma Interventions Before Consultations for Helping Patients Address Their Information Needs Interventions for Preventing Delirium in Hospitalised Patients
Cheek
Cheek
Cheek